Clinical Trial Update: Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia [Phase 1, Phase 2]

View source ↗

Summary

A UC Davis-sponsored clinical trial (Phase 1/2) is evaluating autologous muscle-derived cells for treating oropharyngeal dysphagia; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Dysphagia

Drugs mentioned

• Autologous Muscle Derived Cells (autologous muscle-derived cells)

Snippet

Sponsor: University of California, Davis | Conditions: Oropharyngeal Dysphagia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING